2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM非心脏手术围术期心血管管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
完整摘要 · 中文译文
目的：“2026年AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM非心脏手术围术期心血管管理指南”为指导临床医生对接受非心脏手术的成年患者进行围术期心血管评估和管理提供了推荐意见。 方法：于2022年8月至2023年3月进行了全面的文献检索，以确定在人类受试者中进行、以英文发表、来自MEDLINE（通过PubMed）、EMBASE、Cochrane图书馆、美国医疗保健研究与质量局以及与本病指南相关的其他选定数据库的临床研究、综述和其他证据。 结构：基于新的证据对“2014年ACC/AHA非心脏手术患者围术期心血管评估和管理指南”中的推荐意见进行了更新并整合，以指导临床医生；应告知临床医生，本指南取代先前发布的2014年指南。此外，还制定了基于证据的管理策略，包括针对心血管疾病及相关合并症的药物疗法、围术期监测和设备。
完整摘要 · 英文原文
AIM: The "2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations to guide clinicians in the perioperative cardiovascular evaluation and management of adult patients undergoing noncardiac surgery. METHODS: A comprehensive literature search was conducted from August 2022 to March 2023 to identify clinical studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: Recommendations from the "2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery" have been updated with new evidence consolidated to guide clinicians; clinicians should be advised this guideline supersedes the previously published 2014 guideline. In addition, evidence-based management strategies, including pharmacological therapies, perioperative monitoring, and devices, for cardiovascular disease and associated medical conditions, have been developed.